141 related articles for article (PubMed ID: 14613296)
1. Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome.
Lester S; Danda D; Cavill D; Pile K; Downie-Doyle S; Rischmueller M
Arthritis Rheum; 2003 Nov; 48(11):3293-4. PubMed ID: 14613296
[No Abstract] [Full Text] [Related]
2. Associations of MHC class II alleles in Norwegian primary Sjögren's syndrome patients: implications for development of autoantibodies to the Ro52 autoantigen.
Nakken B; Jonsson R; Brokstad KA; Omholt K; Nerland AH; Haga HJ; Halse AK
Scand J Immunol; 2001 Oct; 54(4):428-33. PubMed ID: 11555411
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome.
Nakken B; Jonsson R; Bolstad AI
Arthritis Rheum; 2001 Mar; 44(3):638-46. PubMed ID: 11263778
[TBL] [Abstract][Full Text] [Related]
4. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
[TBL] [Abstract][Full Text] [Related]
5. A novel polymorphism of the SSA1 gene is associated with anti-SS-A/Ro52 autoantibody in Japanese patients with primary Sjögren's syndrome.
Imanishi T; Morinobu A; Hayashi N; Kanagawa S; Koshiba M; Kondo S; Kumagai S
Clin Exp Rheumatol; 2005; 23(4):521-4. PubMed ID: 16095123
[TBL] [Abstract][Full Text] [Related]
6. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome.
Ohlsson M; Jonsson R; Brokstad KA
Scand J Immunol; 2002 Nov; 56(5):456-69. PubMed ID: 12410795
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of HLA class II genes and autoimmune responses to Ro/SS-A-La/SS-B among Japanese subjects.
Miyagawa S; Shinohara K; Nakajima M; Kidoguchi K; Fujita T; Fukumoto T; Yoshioka A; Dohi K; Shirai T
Arthritis Rheum; 1998 May; 41(5):927-34. PubMed ID: 9588746
[TBL] [Abstract][Full Text] [Related]
8. The 52 000 MW Ro/SS-A autoantigen in Sjögren's syndrome/systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures.
Rhodes DA; Ihrke G; Reinicke AT; Malcherek G; Towey M; Isenberg DA; Trowsdale J
Immunology; 2002 Jun; 106(2):246-56. PubMed ID: 12047754
[TBL] [Abstract][Full Text] [Related]
9. Y RNA derived small RNAs in Sjögren's syndrome: Candidate biomarkers?
Kabeerdoss J; Sandhya P; Danda D
Int J Rheum Dis; 2017 Nov; 20(11):1763-1766. PubMed ID: 29152879
[TBL] [Abstract][Full Text] [Related]
10. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death.
Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
J Immunol; 2006 May; 176(10):6277-85. PubMed ID: 16670339
[TBL] [Abstract][Full Text] [Related]
11. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
Ricchiuti V; Isenberg D; Muller S
J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
[TBL] [Abstract][Full Text] [Related]
12. HLA class II influences the immune response and antibody diversification to Ro60/Sjögren's syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules.
Paisansinsup T; Deshmukh US; Chowdhary VR; Luthra HS; Fu SM; David CS
J Immunol; 2002 Jun; 168(11):5876-84. PubMed ID: 12023392
[TBL] [Abstract][Full Text] [Related]
13. Ro(SS-A) positive Sjogren's/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
Provost TT; Talal N; Bias W; Harley JB; Reichlin M; Alexander EL
J Invest Dermatol; 1988 Oct; 91(4):369-71. PubMed ID: 3262691
[TBL] [Abstract][Full Text] [Related]
14. HLA class II allele polymorphism in Hungarian patients with primary Sjögren's syndrome.
Kovács A; Endreffy E; Petri I; Kovács L; Pokorny G
Scand J Rheumatol; 2006; 35(1):75-6. PubMed ID: 16467049
[No Abstract] [Full Text] [Related]
15. Editorial for Lindop et al. "long-term Ro60 humoral autoimmunity in primary Sjögren's syndrome is maintained by rapid clonal turnover".
Smith K; James JA; Harley JB
Clin Immunol; 2013 Jul; 148(1):110-2. PubMed ID: 23685220
[No Abstract] [Full Text] [Related]
16. [HLA antigens in patients with Sjögren's syndrome].
Moutsopoulos HM; Papasteriades CA; Skopouli FN; Drosos AA
Ter Arkh; 1988; 60(4):28-30. PubMed ID: 3260692
[TBL] [Abstract][Full Text] [Related]
17. HLA-alloantigen associations in Greek patients with Sjögren's syndrome.
Papasteriades CA; Skopouli FN; Drosos AA; Andonopoulos AP; Moutsopoulos HM
J Autoimmun; 1988 Feb; 1(1):85-90. PubMed ID: 3151145
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of antibodies to Ro/SS-A and La/SS-B in subacute cutaneous lupus erythematosus and related conditions.
Zappi E; Sontheimer R
Immunol Invest; 1993 Apr; 22(3):189-203. PubMed ID: 8509157
[TBL] [Abstract][Full Text] [Related]
19. Autoantigen
Hillen MR; Urso K; Koppe E; Lopes AP; Blokland SLM; Pandit A; Slocombe T; van Maurik A; van Roon JAG; Radstake TRDJ
RMD Open; 2020 Jun; 6(2):. PubMed ID: 32540951
[No Abstract] [Full Text] [Related]
20. Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression.
Kapsogeorgou EK; Gourzi VC; Manoussakis MN; Moutsopoulos HM; Tzioufas AG
J Autoimmun; 2011 Sep; 37(2):129-35. PubMed ID: 21632209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]